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Drosophila Activated Cdc42 Kinase Has an Anti-Apoptotic
Function
Jessica A. Schoenherr1, J. Michelle Drennan1, Juan S. Martinez1, Madhusudana Rao Chikka2¤,
Mark C. Hall1, Henry C. Chang2, James C. Clemens1*
1 Department of Biochemistry, Purdue University, West Lafayette, Indiana, United States of America, 2 Department of Biology, Purdue University, West Lafayette, Indiana,
United States of America

Abstract
Activated Cdc42 kinases (Acks) are evolutionarily conserved non-receptor tyrosine kinases. Activating somatic mutations
and increased ACK1 protein levels have been found in many types of human cancers and correlate with a poor prognosis.
ACK1 is activated by epidermal growth factor (EGF) receptor signaling and functions to regulate EGF receptor turnover.
ACK1 has additionally been found to propagate downstream signals through the phosphorylation of cancer relevant
substrates. Using Drosophila as a model organism, we have determined that Drosophila Ack possesses potent anti-apoptotic
activity that is dependent on Ack kinase activity and is further activated by EGF receptor/Ras signaling. Ack anti-apoptotic
signaling does not function through enhancement of EGF stimulated MAP kinase signaling, suggesting that it must function
through phosphorylation of some unknown effector. We isolated several putative Drosophila Ack interacting proteins, many
being orthologs of previously identified human ACK1 interacting proteins. Two of these interacting proteins, Drk and yorkie,
were found to influence Ack signaling. Drk is the Drosophila homolog of GRB2, which is required to couple ACK1 binding to
receptor tyrosine kinases. Drk knockdown blocks Ack survival activity, suggesting that Ack localization is important for its
pro-survival activity. Yorkie is a transcriptional co-activator that is downstream of the Salvador-Hippo-Warts pathway and
promotes transcription of proliferative and anti-apoptotic genes. We find that yorkie and Ack synergistically interact to
produce tissue overgrowth and that yorkie loss of function interferes with Ack anti-apoptotic signaling. Our results
demonstrate how increased Ack signaling could contribute to cancer when coupled to proliferative signals.
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(CRIB) domain. Human ACK1 and Drosophila PR2 are representative members of the CRIB domain containing structural class,
while human TNK1 and Drosophila Ack are members of the
structural class lacking a conserved CRIB domain. Variants
containing a CRIB domain bind GTP liganded CDC42, but
this interaction does not appear to directly influence Ack activity
in vitro [2].
Human ACK1 is the most well characterized member of the
Ack family. Early studies uncovered a role for ACK1 in the
promotion of internalization and down-regulation of activated
epidermal growth factor (EGF) receptor. ACK1 tyrosine phosphorylation is enhanced and ACK1 is co-localized with EGF
receptor after EGF stimulation [8,9]. Knockdown of ACK1
reduces the rate of EGF receptor degradation following EGF
stimulation [5]. While on the surface these data suggest that ACK1
merely serves as a negative regulator of growth factor signaling,
ACK1 activation may additionally propagate downstream signaling. Recent studies support this latter alternative by uncovering a
role for ACK1 as a positive transducer of cell surface receptor
signaling that promotes growth and survival by ACK1 mediated
phosphorylation and activation of downstream components,
including AKT [10] and the androgen receptor [11].

Introduction
Activated Cdc42 kinases (Acks) are non-receptor tyrosine
kinases that are evolutionarily conserved. The founding member
of this family is human ACK1, which was identified as a protein
that binds to CDC42 in its active GTP bound form [1]. Since this
discovery Ack homologs have been found in chordates, arthropods
and nematodes. Ack family members can be divided into three
structural categories based on the presence or absence of four
conserved domain motifs (Figure 1A). All Ack family members
contain an amino-terminal tyrosine kinase domain that is flanked
by a sterile alpha motif (SAM) and a Src homology 3 (SH3)
domain. The carboxy-terminal half of these kinases contains short
proline rich sequences, but lacks any identifiable domains, with the
exception of two tandemly repeated ubiquitin-associated (UBA)
domains located at the extreme carboxy-terminus [2–4]. ACK1
UBA domains have been shown to interact with both mono and
poly-ubiquitinated proteins [5–7] and are thought to play a role in
ACK1 protein turnover [6]. The Caenorhabditis elegans Ack
homolog, Ark-1, contains no UBA domains, placing it in a class
by itself. The other two Ack structural classes can be distinguished
by the presence or absence of a Cdc42/Rac interactive binding
PLoS Genetics | www.plosgenetics.org
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was found in Hodgkin’s lymphoma [28]. It is possible that these
conflicting findings reflect tissue specific responses or complex
dosage sensitivity to TNK1 loss and gain of function.
In order to better understand the physiological role of Ack
family members and determine how Ack might contribute to
cancer, we conducted genetic and biochemical experiments in the
model organism Drosophila melanogaster. Our studies focus on
Drosophila Ack, which has a domain structure resembling human
TNK1 (Figure 1A), but shares significantly higher sequence
identity with ACK1 in all conserved domains including the kinase
domain activation loop. We find that Drosophila Ack possesses
potent anti-apoptotic properties that function downstream of EGF
receptor signaling through an unknown mechanism. This activity
is dependent on Ack kinase function and can be further stimulated
by increased Ras signaling. We have conducted a protein
interaction study and find that many of the same proteins that
associate with human ACK1 also bind to fly Ack. The influence of
these proteins on Ack anti-apoptotic activity was tested, and we
determined that the adapter protein Drk (GRB2) is required for
this activity, while the transcriptional co-activator protein yki
(YAP) functions synergistically with Ack to promote cell survival
and massive tissue overgrowth. Our findings support both antiapoptotic and proliferative roles for Ack family members, which
may contribute to cancer genesis and progression.

Author Summary
A number of recent studies have uncovered an involvement of Ack family members in human cancer. The
majority of these studies focus on human ACK1 and
suggest that ACK1 regulates diverse cancer-relevant
biological functions, including stimulation of proliferation,
blocking programmed cell death, and enhancing metastasis. It is unclear from these studies whether these
biological outcomes are directly controlled by ACK1
activity or if they are indirect consequences of ACK1
signaling. Using Drosophila as a model organism, our study
demonstrates that Ack serves to promote cell survival by
blocking programmed cell death: a mechanism of eliminating excess, damaged, or cancerous cells. We further find
that Ack activity functions synergistically with cell growth
signals to produce massive cellular overgrowth. Our
findings define the physiological role of Ack proteins and
add further support to the value of Ack family members as
therapeutic drug targets for the treatment of cancer.

A pro-survival role for Ack function is consistent with reported
links between activation of Ack family members and cancer
genesis and metastasis. Several somatic missense mutations have
been identified in ACK1 from cancer tissue samples that increase
ACK1 autophosphorylation and promote cellular proliferation
and migration [12]. Amplification of the ACK1 gene in tumors
correlates with a poor prognosis, and ACK1 overexpression in
cancer cell lines increases invasiveness in a mouse metastasis model
[13], while knockdown of ACK1 reduces the migration of human
breast cancer cells [14,15].
Activated ACK1 has been detected in advanced human prostate
cancers [13,16] where it has been shown to phosphorylate three
cancer relevant substrates in prostate cancer cell lines: WWOX
[16], AKT [10], and androgen receptor [11]. WWOX spans the
FRA16D chromosomal fragile site that is frequently disrupted in
human cancers [17–19]. While the molecular function of WWOX
is not known, it has been shown that the growth of tumor cells
lacking WWOX is strongly inhibited by restoring WWOX
expression [20]. ACK1 phosphorylation of WWOX leads to the
polyubiquitination and degradation of WWOX, which correlates
with a tumorigenic role [16]. AKT is a serine/threonine kinase
whose activity promotes cell survival and proliferation, while
deregulation of the AKT signaling pathway is commonly
associated with cancer [21]. ACK1 activation results in tyrosine
phosphorylation and apparent activation of AKT in a PI3K
independent mechanism [10]. Finally, the activity of the androgen
receptor is required for growth of prostate cells. In advanced stages
of prostate cancer, these cells lose their dependence on androgens
for activation of this receptor to become androgen independent
prostate cancer [22,23]. ACK1 has been found to phosphorylate
the androgen receptor, promote androgen independent growth of
prostate cells, and activate transcription of androgen inducible
genes in the absence of androgen [11].
Less is known about the function of Ack family members lacking
CRIB domains, and published studies on TNK1 describe
conflicting functions. TNK1 overexpression in cell culture lines
inhibits cell growth in a kinase dependent manner [24]. Mutant
mice having deletions in the kinase domain of TNK1 develop
spontaneous tumors at a high frequency, which is thought to
originate from hyperactivation of Ras signaling [25,26] and
suggests that TNK1 functions as a tumor suppressor. In contrast to
this function, TNK1 was identified as a potentially oncogenic
tyrosine kinase in a mutagenesis screen [27] and activated TNK1
PLoS Genetics | www.plosgenetics.org

Results
Loss-of-function alleles for both Drosophila Ack and PR2 have
been described previously [29]. Ack86 is a protein null allele that
was generated by imprecise excision of the P element insertion
KG00869 [29,30]. Homozygous Ack86 flies appear visually normal,
although females homozygous for Ack86 are fertile while homozygous males are sterile [29]. Genes that are involved in
programmed cell death regulation and execution are implicated
in Drosophila male fertility because apoptosis-like events are
required for sperm cell individualization [31]. Given that Ack null
males are sterile and that Ack is implicated in human cancer, we
reasoned that Ack might function to regulate apoptosis. Analysis of
one day old adult testis reveals disorganized patterns of elongated
individualizing spermatids in Ack86 homozygous animals compared
to wildtype controls (Figure 1B–1G). The individualization
complexes are displaced from the outer region of the testis coil
to the inner region in Ack mutants (Figure 1B and 1C). Cleaved
caspase-3 staining is also more intense surrounding and associated
with the investment cone structures in newly migrating individualization complexes in Ack mutants compared to controls
(Figure 1D and 1E). Once the individualization complexes have
migrated caudally, the levels of cleaved caspase-3 immunoreactivity are comparable in both Ack mutants and controls (Figure 1F
and 1G). dj-GFP (don juan), which decorates the elongated
mitochondria, was used to visualize spermatids in the testes and
mature sperm in the seminal vesicles [32,33]. Both Ack86
heterozygous and homozygous testes contained dj-GFP-positive
spermatids (arrows, Figure 1H and 1I). However, while dj-GFPpositive sperm were present in heterozygous seminal vesicles
(arrowheads, Figure 1H), Ack86 null seminal vesicles were empty
(arrowheads, Figure 1I), indicating that Ack has a role in mature
sperm production.

Ack Suppresses Cell Death Induced by Hid
The Drosophila compound eye has been used as an experimental
system to assess apoptotic gene function and dissect apoptotic
signaling pathways [34,35]. Ack null flies have eyes that appear
normal as do flies that overexpress Ack or kinase inactive Ack
2
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Figure 1. Ack is required for mature sperm production. (A) A schematic representation of Ack family members is shown. Ack family members
can be grouped into three categories depending on their domain structure. All family members contain an N-terminal tyrosine kinase domain flanked
by sterile alpha motif (SAM) and Src homology 3 (SH3) domains. The C-terminal half of these proteins also contains multiple proline-rich motifs.
Drosophila Ack and human TNK1 do not contain a Cdc42/Rac interactive binding (CRIB) domain. All Ack family members except for Ark-1 in C. elegans
contain an ubiquitin binding associated domain (UBA). (B–G) drICE activity (anti-cleaved caspase-3, green), actin rich investment cones (phalloidin,
red) and DNA (DAPI, blue) are visualized in wild type (Oregon R) and Ack null mutant backgrounds (Ack86/Ack86) during sperm cell individualization. (B
and C) The rostral or coiled region of the testis containing compacted nuclei is shown. The phalloidin staining individualization complexes (*) in wild
type testis travel along the outer edge of the testis coil (B), while in Ack mutant testis they are positioned on the inside of the coil (C). (D–E) Higher
magnification of individualization complexes assembling on condensed DNA (arrowheads) or beginning to migrate (arrows). (F–G) Higher
magnification of more caudal migrating individualization complexes. (H–I) Visualization of dj-GFP fluorescence (green) shows the presence of
elongated spermatids in the testes (arrows) and mature sperm in the seminal vesicle (arrowheads) of Ack86 hetrozygous males (H). (I) Elongated
spermatids are present in the testes of Ack86 homozygous males (arrows) but no mature sperm are present in the seminal vesicle (arrowheads).
doi:10.1371/journal.pgen.1002725.g001

(AckK156A) using a promoter that drives expression in the
developing eye disc (GMR-Gal4, UAS-Ack or AckK156A, Figure 2A–
2E). A previous study reported that eye expression of either Ack or
a kinase dead variant AckK156A using GMR-Gal4 resulted in
massive disorganization of the eye [4]. We find that we can
replicate these phenotypes by doubling the dose of Ack or
AckK156A through the introduction of a second copy of the Ack
transgene (Figure 2F and 2G), indicating that our Ack transgenes
express proteins at comparatively lower levels. Therefore, any eye
size changes seen can be attributed to a genetic interaction with
Ack and not due to Ack overexpression itself.
PLoS Genetics | www.plosgenetics.org

Reaper (rpr), head involution defective (hid) and grim [34,36,37] are
three cell death genes that function as antagonists of Drosophila
inhibitor of apoptosis (DIAP) [38]. The BIR domain of DIAP
binds to initiator and effector caspases to block their proteolytic
activity [39]. IAP antagonists competitively bind to the BIR
domain to dissociate bound caspases [40], leading to caspase
activation and apoptotic cell death. Expression of hid using GMRGAL4 results in a reduced eye size (Figure 2H). Co-expression of
the baculovirus caspase inhibitor p35 with hid completely
suppresses the small eye phenotype (Figure 2I), demonstrating
that the reduction of eye size caused by hid expression is due to the
3
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Figure 2. Ack suppresses small eye phenotypes induced by hid and rpr. The Drosophila eye consists of a hexagonal array of roughly 800
simple eyes called ommatidia. The effect of loss-of-function or expression of Ack family member transgenes on ommatidia patterning and apoptosis
is assessed in a GMR-GAL4 background (B–G), the apoptosis induced backgrounds containing GMR-hid, GMR-GAL4 (H–M) or GMR-GAL4, GMR-rpr (N–S).
Genotypes are indicated in each panel. (A) Oregon R wild type eye. (B) GMR-GAL4 induces weak disorganization of ommatidia patterning. All eyes
containing GMR-Gal4 exhibit this roughness. (C) Ack protein loss (null) produces a slightly smaller eye. (D) Overexpression of Ack results in a slightly
increased eye size. (E) Overexpression of kinase inactive AckK156A is comparable to the Ack null eye in panel C. (F and G) Expression from two copies of
Ack (F) or AckK156A (G) transgenes results in a highly disorganized eye. (H) The death-inducing stimulus hid induces programmed cell death (PCD)
resulting in a small eye phenotype, which serves as the basis of comparison for panels I–M. To aid in eye size comparison we included a dotted oval
that has been reproduced in panels K–M. (I) Expression of the caspase inhibitor p35 blocks PCD and results in an eye size similar to Oregon R. (J) Ack
overexpression suppresses the hid small eye phenotype. (K) Kinase inactive AckK156A is unable to suppress the hid induced small eye phenotype. (L
and M) Ack loss of function (L) and Ack knockdown with RNAi (M) enhances the hid small eye phenotype. (N) The death-inducing stimulus rpr also
induces PCD and results in a small eye phenotype, which serves as the basis of comparison for panels O–S. (O and P) Overexpression of Ack (O) or
AckK156A (P) suppresses the small eye phenotype induced by rpr expression. (Q) Dosage reduction of Ack in an rpr expressing background results in
partial ablation of the eye, leaving a hole in the head exoskeleton in all males and the majority of females with this genotype. (R) Female escapers
having single copy dosage reduction in a rpr expressing background have eye sizes slightly reduced compared to rpr/GAL4 eyes. The dashed oval in
panel N is reproduced in panel R to aid in size comparison. (S) Further reduction of Ack by RNAi mediated knockdown results in loss of all eye tissue
including lens cuticle resulting in a hole in the head exoskeleton of pharate adults. White tissue seen in cuticle holes is brain optic lobe (Q and S).
doi:10.1371/journal.pgen.1002725.g002

either genetically or by RNAi, enhancement of the hid small eye
size is observed (Figure 2L and 2M).
Additionally, we assessed the ability of Ack to suppress the small
eye phenotype induced by rpr expression in the eye. Expression of
wildtype Ack or kinase inactive AckK156A suppresses the small eye
phenotype induced by rpr expression (Figure 2N–2P), suggesting
that non-kinase functions of Ack may be important for suppressing
rpr function. Single copy loss or RNAi mediated knockdown of Ack
expression in rpr expressing fly eyes results in flies that fail to
eclose. Dissection of the pharate adults contained within the pupa
cases revealed stunning phenotypes. Gene dosage reduction of Ack

activation of caspases, resulting in apoptosis of cells that make up
the eye during development.
To determine if Ack contributes to the regulation of cell
survival, we assessed the ability of various Ack transgenes and
alleles to modify the small eye phenotype induced by hid
expression. Co-expression of Ack with hid greatly suppresses the
hid induced small eye phenotype, demonstrating that Ack may
function in a survival role (Figure 2J). Kinase inactive AckK156A
expression fails to modify the hid small eye phenotype, indicating
that Ack kinase activity is required for inhibition of hid induced
eye size reduction (Figure 2K). When Ack function is removed,
PLoS Genetics | www.plosgenetics.org
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adapted a system that had been developed to study regenerative
growth in imaginal discs [45]. In this system UAS-rpr is driven by
rotund (rn)-GAL4, which is active in several imaginal discs including
the wing disc. Reaper expression in this system is further
modulated due to the inclusion of a GAL80ts transgene, which
allows for the temporal activation of UAS controlled transgenes by
raising the temperature from 18uC to 30uC. We determined that a
three hour exposure to 30uC followed by a four hour recovery at
18uC was sufficient to produce an intermediate amount of
programmed cell death in the wing disc pouch as assessed by
TUNEL (Figure S2A). Expression of Ack in this background
decreased the number of TUNEL positive cells in the wing disc
(Figure S2B) while expression of kinase inactive AckK156A or
dosage reduction of Ack using the Ack86 allele increased TUNEL
positive cells (Figure S2C and S2D). We conclude that Ack antiapoptotic function is not limited to the Drosophila eye.

in a GMR-rpr background results in eyes that are partially ablated
(Figure 2Q). A few female escapers eclosed (no male escapers were
found) that had eye sizes slightly smaller than GMR-GAL4; GMRrpr (Figure 2R). Further reduction of Ack dosage by RNAi in the
GMR-rpr background results in complete ablation of the eye
(Figure 2S) with no escapers. In both cases, the ablated eye area is
replaced by a hole in the head cuticle where eye tissue would
normally reside (Figure 2Q and 2S). Further dissection of the
heads of these animals determined that the white tissue visible in
place of the eye is not actually eye tissue, but is instead the optic
lobe region of the Drosophila brain, which in some animals
protrudes outside of the head (as in Figure 2S). Given the shape
and location of the holes, we hypothesize that the eye developed to
a point and then was partially or completely consumed by massive
activation of apoptosis prior to deposition of lens cuticle during
pupa development. We conclude from these experiments that Ack
has anti-apoptotic or proliferative properties capable of overcoming the effects of hid and rpr induced apoptosis.
Finally, overexpression of PR2 or knockdown of PR2 using
RNAi fails to significantly modify the hid or rpr induced small eye
phenotypes (Figure S1). We conclude that unlike Ack, PR2 is
either not involved in survival regulation or may require additional
factors, such as interaction with Cdc42-GTP, for activation of its
kinase activity.

The Anti-Apoptotic Properties of Ack Function
Independently of MAP Kinase Signaling
EGF receptor signaling regulates promotion of apoptosis by hid
expression in the Drosophila eye [35,46]. Specifically, EGF receptor
activation leads to the activation of mitogen activated protein
kinase (MAPK), via the Ras/Raf/MEK pathway. In Drosophila,
activated MAPK directly phosphorylates hid on multiple serine
and threonine residues, which inactivates the pro-apoptotic
function of hid [35]. A schematic representation of this pathway
is shown (Figure 4J). Expression of hidAla5, a mutant in which the
serine or threonine of 5 putative MAPK sites have been changed
to alanine, induces apoptosis which can not be suppressed by
MAPK activity [35].
Vertebrate Ack studies have implicated ACK1 in the turnover
and regulation of EGF receptor signaling [5,7,47]. Therefore, it is
possible that Ack may influence apoptosis by modulating EGF
receptor activity itself or downstream components that ultimately
stimulate MAPK. In order to test this possibility, we assessed the
ability of Ack expression to block programmed cell death
stimulated by hidAla5 expression in the Drosophila eye. Expression
of hidAla5 using the GMR promoter produces a reduced eye size
due to the induction of apoptosis (Figure 4A). The eye size
reduction caused by hidAla5 is greater than that seen by expression
of hid (compare Figure 4A and 2H). This variation could simply be
due to differences in expression levels of the hid transgenes caused
by genomic insertion site positional effects. Alternatively the
differences could be explained by the activity of endogenous
MAPK, which is able to partially block apoptosis induced by hid,
but not by hidAla5.
We selected two proteins that are known to inhibit EGF
receptor signaling or Ras/Raf/MEK signaling. Argos inhibits
EGF receptor activation by competitively binding extra-cellular
EGF, while Gap1 attenuates Ras signaling by facilitating the
conversion of Ras-GTP to the inactive Ras-GDP form [48,49].
Reducing the protein levels of these inhibitors increases signaling
through the EGF receptor pathway, resulting in increased MAPK
activation. Reduction of protein levels can be achieved by
reducing gene dosage through introduction of a single copy of a
strong hypomorphic allele. Single copy loss of either argos or Gap1
has been found to block hid induced apoptosis [35]. However,
single copy loss of argos or Gap1 is unable to block apoptosis
induced by hidAla5 expression and fails to suppress the small eye
size (Figure 4D and 4G and [35]).
If Ack kinase activity blocks apoptosis by enhancing signaling
through the Ras/Raf/MEK pathway, then we would expect that
Ack expression would be unable to suppress apoptosis induced by
hidAla5 expression. However, we find that expression of Ack is able

Ack Suppresses Apoptosis
Ack mediated modification of the hid induced small eye
phenotype could be achieved through two mechanisms. Ack could
function in an anti-apoptotic role to block pro-apoptotic events
initiated by overexpression of hid or rpr. Alternatively, Ack activity
could stimulate cellular proliferation such that apoptotic cells are
replaced by additional cell division of surviving cells. Again, the
Drosophila eye serves as an ideal system to distinguish between these
possibilities. Patterning of the Drosophila eye occurs during the third
instar larval stage. During pattern formation, a wave of
differentiation known as the morphogenetic furrow (MF) moves
anteriorly across the eye imaginal disc [41]. Cells divide
asynchronously ahead of the furrow; however, cell division
following the furrow is tightly regulated and only occurs once
more in a synchronous band that follows behind the furrow known
as the second mitotic wave (SMW) [42]. The GMR synthetic
promoter drives expression of proteins in cells behind the
morphogenetic furrow. Expression of hid via the GMR promoter
has been shown to increase apoptotic cells posterior to the furrow,
but it also induces an additional region of cell division called the
zone of compensatory proliferation (ZCP) that is posterior to the
SMW (Figure 3B) [43,44].
Use of the GMR synthetic promoter to express hid and Ack
transgenes allows us to assess whether Ack expression leads to
inhibition of apoptosis or stimulation of proliferation by TUNEL
staining and BrdU incorporation, respectively, in the third instar
eye disc. Expression of hid in the eye disc produces an increase in
TUNEL positive cells in the region of the SMW and in the most
posterior region of the disc containing the ZCP (compare
Figure 3A and 3B). Expression of Ack in the eye disc substantially
reduces the number of TUNEL positive cells in both regions
(Figure 3C and 3D), while expression of kinase inactive AckK156A
appears to increase the number of TUNEL positive cells (Figure 3E
and 3F). Ack or AckK156A expression does not appear to affect the
number of BrdU positive cells. These data demonstrate that Ack
kinase activity functions in an anti-apoptotic manner (see
Figure 3G for quantification).
It is possible that Ack specifically functions within the eye to
modulate programmed cell death activation. To address this we
PLoS Genetics | www.plosgenetics.org
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Figure 3. Ack expression produces fewer TUNEL positive cells. Proliferation and apoptosis in Drosophila third instar eye discs (posterior is up)
were analyzed by BrdU incorporation (red) and TUNEL (green), respectively. Genotypes are indicated in each panel; the morphogenetic furrow (MF) is
labeled in panels A and B. (A) GMR-Gal4 eye discs have TUNEL positive cells posterior to the second mitotic wave (SMW). (B) Hid expression results in
TUNEL staining posterior to the SMW as well as in the posterior region of the eye disc within the zone of compensatory proliferation (ZCP). (C) Ack
overexpression results in fewer TUNEL positive cells and no observable change in BrdU incorporation patterns. (D) TUNEL staining is also decreased
when Ack is expressed in a hid background. The Ack mediated decrease in apoptosis also decreases the number of BrdU positive cells in the location
of the ZCP as expected. (E and F) Ack kinase dead mutant shows an enhancement of cell death post furrow. (G) Quantification of TUNEL assay from 4
different eye discs per genotype. P-values using a paired t-test verifies that Ack expression is statistically significant compared to control (* = 0.004,
# = 0.0393), whereas, Ack kinase inactive mutant is not statistically significant (* = 0.8007, # = 0.765)(GraphPad Software, QuickCalcs online).
doi:10.1371/journal.pgen.1002725.g003

to suppress the small eye that is induced by both hid and hidAla5
(compare Figure 2H to 2J and Figure 4A to 4B). In both cases, Ack
expression induces a similar fold increase in eye size: roughly a 1.8
fold increase in eye area for hid and a 1.6 fold increase for hidAla5.
Taken together, our data demonstrate that Ack kinase activity
blocks programmed cell death induced by hid through a MAPK
independent mechanism.

raise the possibility that in addition to EGF receptor turnover, Ack
activation may signal to uncharacterized downstream components
to regulate programmed cell death. By using hidAla5 to induce
programmed cell death, we eliminate the pro-survival signaling of
the EGF receptor through MAPK. If EGF signaling activates Ack,
then we would expect that the introduction of mutations that
activate the EGF receptor or downstream components would
result in an increase in the ability of Ack to suppress apoptosis.
This is in fact what we observe: gene dosage reduction of argos or
Gap1 combined with expression of Ack further suppresses the
hidAla5 induced small eye phenotype (compare Figure 4B to 4E
and 4H). These data suggest that Ack may not be directly
activated by the EGF receptor, but may instead be activated at the

Ack Anti-Apoptotic Activity Is Activated by EGF/Ras Signaling
In vertebrates, ACK1 has been shown to be tyrosine
phosphorylated and localized to the EGF receptor upon EGF
stimulation [5,50,51]. This is largely thought to lead to the
internalization and degradation of the EGF receptor. Our findings
PLoS Genetics | www.plosgenetics.org
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Figure 4. Ack anti-apoptotic function is stimulated by EGF receptor/Ras signaling. The Drosophila eye size assay is used to determine how
Ack functions with respect to EGF receptor/MAPK signaling. (A) HidAla5 control eye. (B) Overexpression of Ack results in suppression of PCD induced
by hidAla5 indicating that Ack suppression of apoptosis is independent of hid phosphorylation by MAPK. (C) Kinase inactive Ack fails to suppress PCD,
showing that kinase activity is required for Ack suppression of hidAla5 induced PCD. (D and G) Increased signaling through the MAPK pathway by
single copy loss of argos (D) or Gap1 (G) fails to suppress apoptosis due to the inability of MAPK to phosphorylate and inhibit hidAla5. (E and H) Ack
overexpression combined with single copy loss of argos (E) or Gap1 (H) further suppresses hidAla5 compared to panel B, showing that Ack can be
activated by EGF receptor or Ras signaling. (F and I) AckK156A combined with single copy loss of argos (F) or Gap1 (I) does not suppress hidAla5 PCD. (J)
A schematic of the EGF initiated signaling pathway through MAPK is shown. The MAPK pathway regulates hid induced PCD by phosphorylating and
inhibiting hid. A hid mutant having five serine/threonine phosphorylation sites mutated to alanine (hidAla5) is unable to be inhibited by the MAPK
pathway.
doi:10.1371/journal.pgen.1002725.g004

5E and 5H) on their own, but produces a 25% increase in pigment
cell number when combined with Ack expression (Figure 5F–5H).
These data further support an anti-apoptotic function for Ack that
can be activated by EGF/Ras signaling and suggest that kinase
inactive AckK156A expression enhances programmed cell death
activation in a background not containing overexpression of DIAP
antagonists.

level of Ras-GTP or further down the Raf/Mek/MAPK pathway.
Finally, suppression of apoptosis is absolutely dependent on the
kinase activity of Ack, as AckK156A shows no suppression of the
hidAla5 small eye phenotype either alone or in conjunction with
mutations that enhance EGF receptor or Ras signaling (Figure 4C,
4F and 4I).
Next we sought to determine if Ack activity is able to block
programmed cell death that occurs during normal developmental
tissue patterning. The Drosophila compound eye is composed of 800
simple eye units called ommatidia comprising eight photoreceptors, four cone cells and two primary pigment cells. Each
ommatidium is surrounded by a regular hexagonal array of 12
interommatidial cells comprising six secondary pigment cells, three
tertiary pigment cells and three bristles (Figure 5A). The lattice of
interommatidia cells starts to form at 20% pupal development and
is completed by 33% of pupal development. During this time
period, excess interommatidial cells are selectively eliminated by
programmed cell death. Ack expression results in an increase in
the number of bristles without significantly affecting the number of
pigment cells as assessed at 42% pupa development (Figure 5B and
5H). Expression of AckK156A also increases the number of bristles
within the interommatidia lattice, but results in a 33% decrease in
pigment cell number (Figure 5C and 5H). Single copy loss of argos
or Gap1 does not affect bristle or pigment cell number (Figure 5D,
PLoS Genetics | www.plosgenetics.org

Identification of Ack Interacting Proteins
Our results indicate that Ack kinase activity is anti-apoptotic
and that this activity can be enhanced by activation of the EGF
receptor or its downstream signaling components such as Ras. The
proteins that link EGF/Ras signaling to Drosophila Ack activation
and the downstream targets of Ack are not known. Several
vertebrate ACK1 interacting proteins have been identified (see
[52] for a comprehensive list) and some of these (including AKT,
GRB2, NCK, NEDD4 and WWOX) are attractive candidates for
regulation or transduction of Ack anti-apoptotic signaling.
We utilized a biochemical approach to identify Ack interacting
proteins from Drosophila Schneider 2 (S2) cells (see Materials and
Methods for details). We identified several Ack interacting proteins
that are fly orthologs of known vertebrate ACK1 interacting
proteins, including Clathrin, Drk (GRB2), Hsp83 (HSP90), Dock
(NCK), WASp (WAS) and SH3PX1 (SNX9). The top ten hits
7
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Figure 5. Ack expression genetically interacts with argos and Gap1 loss of function. Genotypes are shown in each panel. (A–G) 42% pupa
retina dissections stained with anti-armadillo and false colored to indicate primary (blue) and secondary or tertiary (red) pigment cells. (A) Oregon R,
wildtype phenotype contains nine interommatidial pigment cells and three bristle cells per ommatidial unit. (B) Overexpression of Ack produces a
duplication of bristles and slight disorganization; however, there is still an average of 9 pigment cells present surrounding each core unit. (C)
Expression of kinase inactive Ack results in fewer but larger pigment cells. (D–E) Gap1 single copy loss (D) and argos single copy loss (E) do not affect
eye patterning. (F–G) Single copy loss of argos (F) or Gap1 (G) in combination with Ack overexpression results in increased interommatidial pigment
cells. (H) Quantification of pigment cell number from all dissections. P-values using a paired t-test verify that the increased number of pigment cells
when Ack is combined with modifiers of the EGF receptor pathway is statistically significant compared to control (* = 0.0001). Loss of pigment cells in
the Ack kinase inactive mutant is also statistically significant compared to the Oregon R control (X = 0.0001)(GraphPad Software, QuickCalcs online).
doi:10.1371/journal.pgen.1002725.g005

but could detect only minor enhancement or suppression,
respectively, of hid or hidAla5 induced programmed cell death,
which appeared to produce an additive effect when combined with
Ack expression (Figure S3).
SH3PX1 RNAi suppresses the hidAla5 induced small eye
phenotype in the Ack expressing background, while Hsp26 and
Magi RNAi enhance the small eye phenotype. These data indicate
that SH3PX1, Hsp26 and Magi may function directly with Ack or
in a parallel pathway to regulate cell survival. Hsp83, Yorkie and
Drk had the largest effect and were further analyzed: RNAi
knockdown of Hsp83 and Yorkie in a hidAla5 and Ack expressing

based on Mascot (probability) score that specifically co-purify with
Ack and are absent from control preparations are shown (Table 1).
RNAi lines for each of the proteins in Table 1 as well as Dock,
Akt1, Nedd4 and Wwox were obtained and used to determine if
knockdown of these proteins influences the ability of Ack to rescue
hidAla5 induced programmed cell death. Weak or no modification
of eye size was seen for the candidate Ack interacting proteins
CG4169, Gale, Hsp23 and Dock. The ACK1 interacting proteins
not identified in our dataset (Akt1, Nedd4 and Wwox) also failed to
robustly modify the eye size in this background (see Figure 6).
Additionally, we obtained loss and gain of function alleles for Akt1,

Table 1. Top ten Ack interacting proteins based on their Mascot score.

Protein

HGNC Ortholog
name

Unique peptide
number

Mascot
scorea

Effect of knockdown on Ack
anti-apoptotic activity

Molecular Function

SH3PX1

SNX9/18/33

21

930

Phosphoinositide binding

enhancement

Yorkie

YAP1

9

612

Transcriptional coactivation

lethal

HSP 83

HSP90AA1

9

375

Molecular chaperone

lethal

CG4169

UQCRC2

9

281

Ubiquinol-cytochrome-c reductase core protein 2

weak enhancement

Gale

GALE

6

272

UDP-galactose 49-epimerase

no effect

Drk

GRB2

5

259

SH2/SH3 adaptor protein

strong suppression

HSP 26

HSPB1

7

259

Molecular chaperone

suppression

Pgam5

PGAM5

3

238

Phosphatase

no effect

Magi

MAGI1

4

226

Guanylate kinase activity

weak suppression

HSP 23

HSPB1

8

215

Molecular chaperone

no effect

a

Mascot score = 210log(P) where P is the probability that the match is incorrect.
doi:10.1371/journal.pgen.1002725.t001
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substrate, but serves as an adapter protein that functions to
position Ack to receive and propagate anti-apoptotic signals.

background resulted in flies that failed to eclose from pupa cases,
while Drk knockdown produced adults that had greatly reduced
eye size (Figure 6E). Based on our results, we elected to further
characterize the requirement of Drk and yki for Ack anti-apoptotic
function.

Yorkie and Ack Genetically Interact to Promote
Proliferation and Block Apoptosis
Yorkie (yki) is the Ack interacting protein that has the second
highest Mascot score. Yki has not been previously identified as an
Ack family member binding protein, but is an attractive candidate
due to its role as a transcriptional co-activator that interacts with
the TEAD/TEF family protein Scalloped to control expression of
proliferative (Cyc E) and anti-apoptotic genes (DIAP) [54,55].
Nuclear yki is shuttled to the cytoplasm by the FERM-domain
containing protein Expanded [56]. Cytoplasmic yki is subject to
inactivation by the Salvador-Warts-Hippo signaling pathway,
which functions to regulate organ size [57]. Yki phosphorylation
by the serine/threonine kinase Warts leads to yki interaction with
cytoplasmic 14-3-3 proteins and yki sequestration from the nucleus
[58]. Since yki is a transcriptional co-activator of both proliferative
and anti-apoptotic genes, it is tempting to speculate that Ack
functions to promote the nuclear localization of yki to enhance
transcriptional activation of yki target genes. We conducted a
series of experiments to test this hypothesis and further characterize the interactions between Ack and yki.
We have shown that expression of Ack in the Drosophila eye
blocks native apoptosis (Figure 3C) and produces a slightly larger
and mildly rough eye (Figure 8B). Expression of yki in the eye
produces a strong overgrowth phenotype in which eye tissue

Drk Is Required for Ack Anti-Apoptotic Function
Drk is an adaptor protein made up of SH2 and SH3 domains
and is the fly ortholog of vertebrate GRB2 and C. elegans Sem5. In
both vertebrates and C. elegans, these proteins have been shown to
interact with their Ack equivalents to negatively regulate EGF
receptor signaling [50,53]. We find in the absence of Ack
overexpression, Drk RNAi does not influence hid or hidAla5
induced apoptosis as assessed by modification of eye size (compare
Figure 7A to 7D and 7B to 7E). Expression of Ack suppresses
hidAla5 induced cell death (compare Figure 7B to 7C), and
remarkably this suppression can be eliminated by RNAi knockdown of Drk (compare Figure 7B and 7C to 7F). We conclude
from these experiments that Ack requires Drk function for
transmission of its anti-apoptotic signal. Drk immunoprecipitation
followed by western analysis shows that Drk and Ack exist in a
physical complex, and this interaction can be enhanced by
increasing Ack expression levels (Figure 7G). We further find that
the Ack that co-precipitates with Drk is tyrosine phosphorylated,
as assessed by western analysis, but we are unable to detect any
tyrosine phosphorylation on Drk itself (Figure 7H). Taken
together, these data support a model in which Drk is not an Ack

Figure 6. RNAi knockdown of Ack interacting proteins identify Drk as part of the Ack survival pathway. The involvement of Ack
physically interacting proteins identified in our studies and elsewhere is tested in the Drosophila eye size assay by RNAi mediated knockdown. (A)
HidAla5, Ack overexpression baseline eye. To aid in eye size comparison we included a dashed oval that has been reproduced in all panels. (B–I and K–
L) RNAi transgenes are tested in the GMR-hidAla5, GMR-Gal4/+; UAS-Ack/+ background containing a UAS-Dcr-2 transgene on chromosome II or III
depending on UAS-RNAi transgene location. The UAS-RNAi transgene target is indicated in each panel. (J) GMR-hidAla5, GMR-Gal4/+; UAS-Ack/Akt104226
(Akt1 loss of function allele). (B, C and L) SH3PX1, CG4169 and Wwox RNAi result in further suppression of PCD. (E–G) Drk, HSP23 and Magi RNAi result
in enhancement of PCD. (D, and H–K) The other candidates do not modify the hidAla5 Ack baseline and thus are most likely not a part of the Ack antiapoptotic pathway.
doi:10.1371/journal.pgen.1002725.g006
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eye. We find that Ack and yki result in similar magnitudes of
suppression of hid small eye size (Figure 8E–8G); however, yki
expression in the hid background produces eyes displaying a loss of
eye pigment whereas Ack expression results in uniformly
pigmented eyes. Co-expression of Ack and yki in the GMR-hid
background further suppresses the hid small eye phenotype, but
still results in an eye with comparable pigment loss to yki
suppression of hid alone (Figure 8H). The fact that we observe
different results for Ack (Figure 8F) versus yki (Figure 8G)
suppression of the hid induced small eye phenotype suggests that
Ack suppresses apoptosis via a mechanism that is independent of
yki mediated transcriptional co-activation.

Ack Does Not Promote Yki Nuclear Translocation or
Transcriptional Activation of Yki Targets
Based on our data, it is unlikely that Ack enhances yki nuclear
localization and subsequent activation of yki transcriptional
targets. To confirm this we assessed the effect that Ack has on
yki subcellular localization. Ack-mCherry expressed in R-cells is
excluded from the nucleus and localizes throughout the cytoplasm.
The highest concentrations of Ack are at apical membrane
surfaces and in puncta near the nuclear envelope and within axons
(Figure S4A). Yki-GFP expressed in R-cells has a localization
pattern similar to Ack-mCherry, exhibiting nuclear exclusion with
cytoplasmic, apical membrane and axonal puncta localization;
however, the highest levels are seen ringing the nucleus with
puncta apparent on or near the nuclear envelope (Figure S4B).
Co-expression of Ack-mCherry and yki-GFP reveals overlapping
expression patterns in the apical membrane regions and both axon
and nuclear localizing puncta (Figure S4C–S4E). Co-expression of
Ack and yki does not result in increased nuclear localization of
either protein but does increase the yki localization to puncta
surrounding the nucleus. Consistent with these data, we detected
no increases in beta-galactosidase expression in the yki transcriptional activity reporter line ex697 when Ack is overexpressed
(Figure S5A–S5F). These data are consistent with Ack and yki
participating in physical interactions outside of the nucleus that do
not lead to nuclear import of either protein or transcriptional upregulation of yki targets.

Figure 7. Drk is required for Ack anti-apoptotic activity. The
influence of Drk loss of function on PCD was assessed using the eye size
assay. Genotypes are indicated in each panel. Hid (A) and hidAla5 (B)
backgrounds were combined with RNAi mediated knockdown of Drk (D
and E). Hid and hidAla5 unmodified eye sizes have been outlined with
dotted and dashed ovals that have been reproduced in panels D and E
respectively. Drk knockdown in the hid (D) or hidAla5 (E) backgrounds
results in no reduction in eye size but a loss of pigmentation, which is
more pronounced with hidAla5. (C and F) The requirement of Drk for Ack
anti-apoptotic function is assessed. (C) HidAla5, Ack overexpression
baseline eye. (F) RNAi mediated knockdown of Drk inhibits Ack’s ability
to suppress programmed cell death. The dashed oval from panels B and
E is reproduced here to show that the eye size is similar to the hidAla5
baseline. (G and H) Western analysis of Drk immunoprecipitation. (G)
Drk was immunoprecipitated with anti-Drk 12201 antiserum and
blotted with Ack (top panel) and Drk (bottom panel) antibodies. Ack
co-precipitates with Drk from extracts prepared from S2 cells expressing
endogenous Ack (S2 lane) as well as Ack overexpressing S2 cells (Ack OE
lane). Ack knockdown by RNAi eliminates the immunoreactive band,
confirming that it is Ack (Ack RNAi lane). (H) Drk was immunoprecipitated from Ack overexpressing S2 cells using two different Drk antisera,
12201 (01) and 12203 (03), and blotted with an anti-phosphotyrosine
antibody (4G10). An immunoreactive band corresponding to phosphoAck is indicated (P-Ack). No immunoreactivity is detected where Drk is
predicted to run (P-Drk).
doi:10.1371/journal.pgen.1002725.g007

Yki Regulates Ack Anti-Apoptotic and Proliferative
Functions
We tested the effect of protein dosage on the ability of Ack or yki
to suppress hid induced apoptosis. Single copy loss of yki
dominantly suppresses Ack anti-apoptotic function (compare
Figure 8F to 8J), while single copy loss of Ack has no effect on
the ability of yki to suppress the hid induced small eye phenotype
(compare Figure 8G to 8K). Single copy loss of yki did not
noticeably modify the hid induced small eye in the absence of Ack
suggesting that yki loss is specifically affecting Ack function
(Compare Figure 8E to 8I). Finally, we employed yki RNAi to
further reduce the levels of yki in the eye. Yki RNAi in the GMRhid background resulted in flies that die as pharate adults.
Expression of exogenous Ack in this background rescues lethality
and produces eye sizes smaller than yki single copy loss (Figure 8l).
Taken together these data support a model in which Ack antiapoptotic function is activated by yki protein.
Yes associated protein (YAP) is the vertebrate homolog of yki.
Mutant versions of YAP have been generated and studied in the
Drosophila eye. The YAP S127A mutation prevents phosphorylation by LATS family kinases, thereby increasing YAP nuclear
localization. The YAP S94A mutation disrupts the binding of YAP
to TEAD family DNA binding proteins. Expression of YAPS127A

protrudes out of the normal curvature of the eye (Figure 8C). Coexpression of Ack and yki reveals a synergistic effect, producing
massive overgrowth (Figure 8D). We draw two conclusions from
these results. First, Ack and yki expression in the eye result in
different phenotypes, suggesting that Ack may not activate yki
transcriptional activity. Second, Ack activity is not limited to
prevention of apoptosis, but can also enhance proliferation when
combined with proliferative signals.
Next we sought to determine if Ack and yki expression resulted
in similar suppression of hid induced programmed cell death in the
PLoS Genetics | www.plosgenetics.org
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Figure 8. Ack and Yorkie genetically interact. The eye size assay was employed to assess the involvement of Yorkie (yki) in Ack suppression of
apoptosis. Genotypes are indicated on each panel. (A) GMR-Gal4 control eye. (B) Ack overexpression does not modify GMR-Gal4 roughness, but does
result in a slightly increased eye size. (C) Yki overexpression results in a disorganized eye that is overgrown. (D) Ack and yki overexpression yields a
massively overgrown eye. (E) Hid small eye control phenotype. (F) Ack overexpression suppresses hid induced PCD. The eye is outlined with a dashed
oval that has been reproduced in panels G and J–L to aid in size comparisons. (G) Yki overexpression in the hid background not only results in hid
PCD suppression, but also shows a reduction in pigmentation. (H) Yki and Ack overexpression in a hid background results in further PCD suppression
than either transgene alone, but still shows loss of pigmentation. (I) Yki single copy loss results in an eye that is a similar size as the hid control
phenotype, shown by a dotted oval. (J) Single copy loss of yki reduces the ability of Ack to suppress hid induced PCD. (K) Single copy loss of Ack does
not modify yki suppression of PCD. (L) Knockdown of yki by RNAi further interferes with the ability of Ack to suppress hid induced apoptosis
compared to yki single copy loss. (M) Exogenous expression of human YAPS94A/S127A does not affect eye size. (N) Combined expression of YAPS94A/S127A
and Ack results in an increased eye size.
doi:10.1371/journal.pgen.1002725.g008

appear to be more closely related to vertebrate TNK1 because
both proteins lack a CRIB domain, Ack is most similar to
vertebrate ACK1 based on sequence identity of all shared protein
domains. Additionally we find that many of the proteins that
interact with ACK1 also interact with fly Ack. Therefore, we feel
that the conclusions drawn in this study will likely be applicable to
vertebrate ACK1 function.
We have shown that Ack function can suppress programmed
cell death induced by hid or rpr expression in the developing eye
and wing discs. Our overexpression studies reveal that Ack kinase
activity is required for suppression of apoptosis induced by hid but
is unnecessary for suppression of rpr-induced apoptosis. We
further show that Ack loss of function enhances cell death induced
by expression of both of these genes and determine that Ack is
critically required for the survival of rpr expressing eye tissue. The
molecular mechanisms underlying these differential requirements

in the fly eye leads to an overproliferation phenotype, while
expression of the double mutant YAPS94A/S127A produces eyes that
are normal in appearance due to an inability to bind Sd and
activate YAP/yki target gene transcription [59]. We obtained
YAPS94A/S127A and found that co-expression of YAPS94A/S127A
with Ack leads to an increase in eye size (compare Figure 8M and
8N), indicating that YAP can also genetically interact with Ack to
enhance proliferation even when it cannot serve as a transcriptional co-activator with Scalloped.

Discussion
Drosophila melanogaster has two Ack family members: Ack and
PR2. We have found that Ack possesses anti-apoptotic properties,
while PR2 either does not possess anti-apoptotic properties or
requires activators not present in our assay system. While Ack may
PLoS Genetics | www.plosgenetics.org
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are not known. Hid and rpr are known to function in a multimeric
protein complex on the mitochondria outer membrane to promote
apoptosis [60]. Both hid and rpr are able to stimulate apoptosis by
competing with initiator and effector caspases for DIAP binding,
but rpr additionally induces DIAP auto-ubiquitination leading to
DIAP degradation. While Ack kinase activity may be important
for aspects of hid complex regulation, it is tempting to speculate
that the UBA domains of Ack may play a critical role in the
modulation of DIAP or rpr ubiquitination and stability.
EGF receptor signaling has been shown to activate ACK1 in
vertebrates, and we find that EGF signaling enhances the antiapoptotic function of Ack in Drosophila. ACK1 negatively regulates
EGF receptor signaling by stimulating endocytosis of activated
receptor complexes. We have evidence supporting that Drosophila
Ack, in conjunction with SH3PX1, functions in a similar manner,
which will be described elsewhere. In Drosophila, EGF signaling is
anti-apoptotic through the activation of MAPK, which phosphorylates and inactivates hid. If Ack affected apoptosis exclusively
through attenuation of EGF signaling, then we would expect that
Ack loss of function would be anti-apoptotic while gain of function
would be pro-apoptotic, which is opposite to what we observe. By
using the hidAla5 mutant, we demonstrate that Ack does not
modulate programmed cell death through activation of MAPK.
The anti-apoptotic function of Ack is surprisingly robust
compared to other proteins that we have tested. Our studies show
that activity of the kinase domain contributes to Ack anti-apoptotic
function. Based on this, we conclude that Ack propagates antiapoptotic signals by phosphorylating downstream targets. Several
ACK1 substrates have been identified that are attractive
candidates for the regulation of programmed cell death: the
putative tumor suppressor WWOX, the apoptosis inhibiting
protein kinase AKT and the caspase-cleaved ubiquitin E3 ligase
NEDD4. Akt1 loss and gain of function alleles (Figure S3) and
Nedd4 RNAi (Figure 6K) fail to significantly modify hid induced
small eye phenotypes. Wwox RNAi is able to suppress hid induced
apoptosis but not nearly as robustly as Ack expression (Figure S6).
Since ACK1 mediated phosphorylation of WWOX leads to
WWOX destruction, we would predict that Wwox RNAi would
phenocopy Ack expression in our assay system, but it is unable to
reproduce the magnitude of Ack anti-apoptotic function. This does
not rule out Wwox as an anti-apoptotic substrate target of Ack, but
it demonstrates that Wwox is not the only cell death relevant
substrate of Ack. It is worth noting that hid and rpr act fairly late
within the programmed cell death pathway, being just a step
upstream of initiator caspase activation. Therefore, Ack must
target substrates that have activities influencing hid, rpr or events
at the level of caspase activation.
We identified several Ack physically interacting proteins using a
tandem affinity purification strategy. Many of these have
vertebrate homologs that have been previously determined to
interact with ACK1. We found that Drk and yki have the most
pronounced effect on Ack’s anti-apoptotic properties and chose to
further characterize their contribution to Ack signaling. Drk is the
fly ortholog of vertebrate GRB2, which has previously been
described as an ACK1 and TNK1 interacting protein. In the case
of TNK1, GRB2 is tyrosine phosphorylated by TNK1, which
disrupts the ability of GRB2/SOS complexes to activate Ras [26].
This does not appear to be the case for Drosophila Ack, because
even though Drk forms a complex with tyrosine phosphorylated
Ack, we find no evidence of tyrosine phosphorylation on Drk.
Rather, our data support that Drk association with Ack is required
for Ack anti-apoptotic properties. We propose that Drk SH3
domains likely interact with PXXP motifs in the C-terminal half of
Ack similar to the interaction described in vertebrates [50]. This
PLoS Genetics | www.plosgenetics.org

interaction could then lead to the recruitment of Ack into protein
complexes required for Ack activation.
Yki is a transcriptional co-activator that regulates expression of
genes with proliferative and anti-apoptotic functions. The vertebrate homolog of yki is Yes Associated Protein (YAP), which has
not previously been identified as an ACK1 or TNK1 interacting
protein. Yki and YAP studies have focused primarily on the
pathways that regulate their function as transcription factors.
Given the role of yki and YAP in transcriptional control of
proliferative and anti-apoptotic genes, it would seem likely that
Ack activity leads to enhancement of yki function. However, this
does not appear to be the case because Ack overexpression does
not lead to increased yki nuclear localization or increased
expression of yki target genes. Rather, our data indicate that yki
directly interacts with Ack in the cytoplasm and functions to
regulate Ack activity. In support of this, we have found that Ack
colocalizes with yki, and yki dosage reduction suppresses Ack antiapoptotic function. Yki contains two WW domains, which may
interact with conserved PPXY motifs that are present in the region
flanked by the SH3 and UBA domains of Ack family members. In
vertebrates, these PPXY motifs have been shown to interact with
WWOX, which also contains two WW domains [16]. Further
studies are required to define how yki and Ack interact.
Yki expression in the fly eye produces an overgrowth phenotype
that is indicative of its role in regulating proliferation. Ack
overexpression produces a slightly larger eye due to inhibition of
apoptotic events that occur during normal eye development.
Simultaneous expression of yki and Ack results in a synergistic
effect that produces enormous eyes. These results reveal that in
addition to anti-apoptotic function, Ack can also enhance proliferation. This illustrates how increased Ack signaling could contribute
to cancer when coupled to proliferative signals. Indeed, our results
are consistent with recent reports of ACK1 activating somatic
mutations [12] and gene amplification [13] being associated with
human cancers. At present the key anti-apoptotic substrates of Ack
and their mechanisms of action remain to be determined. With their
discovery will come a better understanding of Ack signaling and
potentially new targets for cancer interventions.

Materials and Methods
Fly Lines
Standard Drosophila genetic technique was used for all crosses and
transgenesis. All flies were raised at 25uC with 70% relative
humidity. Fly lines used are as follows: Oregon R, GMR-Gal4/CyO,
GMR-hidG1/CyO, GMR-p35, P{lacW}Gap1/TM3, argosD7/TM3,
UAS-Dcr-2/CyO, UAS-Dcr-2, P{PZ}Akt104226/TM3, GMR-rpr/
TM6B, UAS-yki-GFP (Bloomington Stock Center); UAS-PR2 and
Ack86/TM3 (a gift from Nicholas Harden, Simon Fraser University);
GMR-hidAla5/CyO (a gift from Andreas Bergmann, M.D. Anderson
Cancer Center); UAS-yki and FRT42, ykiB5/CyO (a gift from Nic
Tapon, London Research Institute); UAS-YAPS127A and UASYAPS94A/S127A (a gift from Zhi-Chun Lai, Pennsylvania State
Univeristy); rn-GAL4, UAS-rpr, tub-GAL80ts/TM6B, GAL80 (a gift
from Ken Irvine, Rutgers University); UAS-PR2 RNAi, UAS-Ack
RNAi, UAS-SH3PX1 RNAi, UAS-CG4169 RNAi, UAS-Gale RNAi,
UAS-Drk RNAi, UAS-HSP 26 RNAi, UAS-HSP 23 RNAi, UAS-HSP 83
RNAi, UAS-yki RNAi, UAS-14-3-3 epsilon RNAi, UAS-Magi RNAi,
UAS-Dock RNAi, UAS-Nedd4 RNAi, UAS-Wwox RNAi (Vienna
Drosophila RNAi Center, VDRC).
UAS-Ack constructs were produced by sub-cloning Ack from
pMT/V5-Ack plasmid (a gift from Jack Dixon, UCSD) into
EcoRI/XhoI sites in the pUASt vector. Transgenic flies (UAS-Ack/
TM6B, UAS-AckK156A/TM6B and UAS-Ack-mCherry) were made
12
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by microinjecting pUASt-Ack DNA constructs into yw flies. GMRhid and GMR-hidAla5 were recombined with GMR-Gal4 to aid in the
Drosophila eye size assays.

Wing Disc Analysis
rn-GAL4, UAS-rpr, tub-GAL80ts/TM6B, GAL80 flies were crossed
to yw, UAS-Ack, UAS-AckK156A or Ack86 and the progeny were raised
at 18uC until third instar larva appeared. Male third instar larva
were isolated and transferred to new vials that contained
approximately 1 ml of mechanically churned food. Vials were
then placed in a 30uC water bath for 3 hours and then returned to
18uC for four hours. Wing discs were dissected, fixed and
subjected to TUNEL analysis as described above.

Testis Analysis
Newly eclosed males were dissected in PBS and transferred to
PBX (PBS+0.1% Triton X-100) containing 4% formaldehyde for
20 minutes. Testis were washed with PBX, incubated with anticleaved caspase-3 (cell signaling, 1:75) overnight at 4uC followed
by anti-rabbit Alexa 488 (1:500, Invitrogen) secondary antibody
for 3 hours. F-actin was stained using 1 unit of Alexa 568
phalloidin (Invitrogen) and nuclei were stained with Hoechts used
at 1:10,000 dilution (Thermo Scientific). Samples were mounted in
VECTASHIELD and images were acquired using a Disk
Scanning Unit-enabled Olympus BX61 microscope equipped
with a Hamamatsu DCMA-API camera.

Pupa Retina Analysis
Crosses were established at 22uC and larvae allowed to pupate
to 42% pupal development. Retinas were dissected in standard
saline buffer (2 mM KCl, 128 mM NaCl, 4 mM MgCl2, 1.8 mM
CaCl2, 36 mM sucrose, 5 mM HEPES pH 7.1). Immediately after
dissection, retinas were immersed in fixative (10 mM periodate,
75 mM lysine, 2% paraformaldehyde in 16 PBS) with 0.05%
saponin for 20 minutes. Following fixation, retinas were washed in
PBX and incubated with mouse anti-Armadillo (1:30; DSHB) and
Alexa 568 phalloidin (Molecular Probes) with 5% goat serum
overnight at 4uC. Retinas were then washed in PBST and
incubated in Alexa 646 (Molecular Probes) and Alexa 488
conjugated secondary antibodies for 3 hours at room temperature.
Retinas were then washed with PBST and mounted in mounting
medium (0.25% n-propyl gallate, 50% glycerol in PBS). Confocal
images were taken and the images were inverted and printed. For
easier analysis the pigment cells were false colored.

Hid and HidAla5 Eye Cell Death Modifier Assay
GMR-Gal4, GMR-hid/CyO or GMR-Gal4, GMR-hidAla5/CyO
virgin females were crossed with male flies of various genotypes.
Color images were taken by removing the heads and mounting
them with rubber cement onto 1 ml micropipettes and imaged
submerged in water using a Zeiss Discovery.V12 dissecting
microscope equipped with a color camera and a plan S 1.0X
FWD 81 mm objective. All images were acquired and processed
identically. Images were taken at 856 magnification, cropped &
rotated using Adobe Photoshop and then scaled uniformly using
Microsoft PowerPoint.

Purification of Ack Interacting Proteins and Mass
Spectrometry

Eye Disc Analysis
Images were acquired using a Zeiss LSM 710 confocal
microscope. For immuno and direct fluorescence, 3rd instar larva
were dissected in PBS and fixed in 4% paraformaldehyde for
30 minutes. Eye discs expressing GFP and mCherry fusion
proteins were washed prior to mounting in VECTASHIELD
(Vector Laboratories) and fluorescent imaging. For analysis of
non-tagged proteins, the eye discs were blocked in PBTN (10%
normal goat serum in PBT (PBS+0.5% Triton X-100)) and
incubated overnight in PBTN containing antibodies directed
against Ack (JCD2, 1:1000) and beta-galactosidase (40-1a, 1:50,
Developmental Studies Hybridoma Bank, University of Iowa)
followed by one hour incubations with goat anti-mouse Alexa 568
(1:500) and goat anti-rabbit Alexa 488 (1:500) secondary
antibodies.
For TUNEL and BrdU analysis, 3rd instar larva imaginal discs
were dissected in PBS and incubated in BrdU incorporation
solution (5 ml/ml BrdU (Sigma) in PBS) for 1 hour at room
temperature (RT). Eye discs were then washed with PBS and fixed
with 4% paraformaldehyde for 30 minutes. The samples were
blocked overnight at 4uC with PBTN.
TUNEL labeling: Eye discs were incubated in 99 mM NaCitrate+0.1% Trition X-100 for 30 minutes at 65uC, washed and
incubated in TUNEL assay solution (In Situ Cell Death Detection
Kit, Roche) for 1 hour at 37uC rotating in the dark. Eye discs were
then washed in PBT and once in PBS then treated with 2N HCl
for 30 minutes and neutralized with 100 mM Borax for 2 minutes.
They were then washed with PBT and re-blocked with PBTN for
1 hour at RT.
BrdU Staining: tissue was incubated overnight at 4uC in antiBrdU primary antibody (1:20, G3G4, Developmental Studies
Hybridoma Bank, University of Iowa), washed and incubated for
3 hours at RT with goat anti-mouse Alexa 568 (1:500) secondary
antibody. Eye discs were washed twice with PBT, twice with PBS
and then mounted in VECTASHIELD.
PLoS Genetics | www.plosgenetics.org

Schneider 2 (S2) Drosophila cells were transfected with pMT/V56xHis-Flag-Ack and pCoHygro in Schneider’s S2 medium
(Invitrogen). Stably transfected cells were obtained by hygromycin
selection (200 mg/ml, Invitrogen). Both control S2 cells (nontransfected) and 6xHis-Flag-Ack expressing S2 cells were subjected
to the following purification procedure and mass spectrometry
analysis. Cells were grown in a liter spinner flask and induced with
0.7 mM CuSO4 for 1 day. Cells were harvested and suspended in
RIPA buffer (150 mM NaCl, 1% Igepal CA-630, 0.5% sodium
deoxycholate, 0.1% SDS, 50 mM Tris pH 8.0, .2 mM sodium
orthovanadate, 10 mM NaF, 0.4 mM EDTA pH 8, 10% glycerol)
then lysed by sonication. 6xHis-Flag Ack was captured using Flag
M2 resin (Sigma) and Ack was eluted with 100 mg/ml 36 flag
peptide (Sigma). A second level of purification was achieved by
adding a Phospho-tyrosine resin (protein A with cross-linked 4G10
antibody (Millipore)) to the flag elution. The final elution was with
100 mM triethanolamine (TEA) pH 11.5 and dried using a
speedvac.
To prepare samples for mass spectrometry, purified proteins
were resuspended in 50 mM ammonium bicarbonate with 0.2%
RapiGest (Waters). 5 mM tris (2-carboxyethyl) phosphine was
added and the sample was heated at 56uC for 30 minutes. After
heating, 15 mM Iodoacetamide was added and vortexed for
1 hour in the dark. 1 mg trypsin was added to digest the protein
overnight at 37uC. 0.5 ul of concentrated HCl was added to
degrade the RapiGest. The sample was then centrifuged and dried
using a speedvac and subsequently resuspended in 5% acetonitrile,
0.1% trifluoroacetic acid prior to liquid chromatography and
electrospray ionization-MS/MS analysis. An Agilent 1100 nanoHPLC system was used to separate peptides using Zorbax C18 trap
and 75 um6150 mm capillary columns. Peptides were eluted with
a gradient of increasing acetonitrile in 0.1% formic acid at a flow
of 300 nL/min and injected into a Thermo LTQ-Orbitrap using a
13
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nanoelectrospray source. The Orbitrap was operated in datadependent tandem MS mode with one MS scan followed by 3
tandem MS scans and a dynamic exclusion window of two
minutes. Data were searched against a database of Drosophila
melanogaster protein sequences using both Sorcerer (Sage-N
Research) and Mascot (MatrixScience) search software. Similar
results were obtained with both. Database searches were set with a
mass tolerance of 25 ppm, full tryptic cleavage, one allowed miscleavage, and carbamidomethyl cysteine modification. Identified
proteins were considered specific Ack binding partners only if the
following stringent criteria were met: no peptides from the protein
were observed in the control sample; at least 3 unique peptides
were identified with Mascot ion scores above the designated
threshold significance value; and Mascot protein scores were
above 100.

the genotypes are indicated in each panel. (A9–D9) the TUNEL
positive cell images from A–D are superimposed on bright field
micrographs of the eye disc. (A) UAS-rpr induces programmed cell
death in the wing disc. (B) Ack overexpression results in fewer
TUNEL positive cells. (C–D) Expression of kinase inactive Ack or
Ack gene dosage reduction shows an increase in TUNEL positive
cells.
(TIF)
Akt1 does not modify the hid small eye phenotype.
The eye size assay was used to assess the ability of Akt1 loss and
gain of function to modify hid induced programmed cell death.
Genotypes are indicated in each panel. To aid in eye size
comparisons, the dotted oval in panel A is reproduced in panels B–
D, the dashed oval in panel E is reproduced in panels F–H and the
dashed oval in panel I is reproduced in panels J–L. (A–D) The
GMR-hid, GMR-GAL4 genetic background combined with (B) Akt1
overexpression, (C) introduction of a loss of function allele
Akt104226 or (D) overexpression of the constitutively activated
mutant Akt1T342D/S505D. (E–H) The GMR-hidAla5, GMR-GAL4
genetic background combined with (F) Akt1 overexpression, (G)
the loss of the function allele Akt104226 or (H) constitutively
activated Akt1T342D/S505D overexpression. (I–L) Ack overexpression in the GMR-hidAla5, GMR-GAL4 genetic background combined with (J) Akt1 overexpression, (K) the loss of the function
allele Akt104226 or (L) constitutively activated Akt1T342D/S505D
overexpression.
(TIF)
Figure S3

Immunoprecipitation and Western Analysis
S2 cells and S2 cells expressing exogenous Ack were grown to
confluency, counted and plated in a 6-well dish containing S2
medium at a concentration of 16106 cells/1 ml/well. Ack dsRNA
(15 mg) was added to a well with S2 cells and incubated for
45 minutes before the addition of 2 ml S2 media supplemented
with 10% FBS to all wells. After 24 hours, 0.7 mM CuSO4 was
added to the Ack overexpressing line to induce Ack expression.
The cells were harvested after an additional 48 hours and lysed in
RIPA buffer by sonication. Cleared lysate was achieved from a
tandem centrifugation procedure of 10 minutes at 4uC on a
tabletop centrifuge and then transferred to an ultracentrifuge for
30 minutes at 100,0006g at 4uC. The lysates were incubated with
anti-Drk antibody (a gift from Efthimios Skoulakis, Alexander
Fleming Biomedical Sciences Research Center, Greece) on ice for
1 hour before adding 50 ml slurry of immobilized protein A resin
(G-Biosciences) for 1K hours at 4uC with continuous rotation.
The samples were washed with RIPA buffer.
Drk IP samples were eluted in SDS-PAGE sample buffer and
subjected to SDS-PAGE. The protein was transferred to an
immobilon-P transfer membrane (Millipore) and blocked for
1 hour with 5% milk. Drk and Ack were detected using antiDrk 12201 antibody (1:3,000, overnight) and anti-JCD2 (1:1,500,
1 hour; [61]) primary antibodies and goat anti-rabbit secondary
antibody (1:10,000) for 1 hour and detected with ECL detection
reagent (Thermo Scientific).

Figure S4 Ack-mCherry and yki-GFP subcellular localization in

R-cells. Single plane confocal images show the subcellular
localization of Ack-mCherry and yki-GFP expressed individually
(A and B) or simultaneously (C–E) in third instar R-cells. Nuclei
appear as open ringed structures in all panels. (A) Ack-mCherry is
nuclear excluded and is found in the cytoplasm and in numerous
cytoplasmic puncta. (B) Yki-GFP is also largely nuclear excluded
and more diffusely distributed throughout the cytoplasm compared to Ack. (C–E) Simultaneous expression of Ack-mCherry (C)
and yki-GFP (D) does not lead to increased nuclear localization of
either protein, but does induce yki to co-localize into puncta with
Ack. (E) An overlay of panels C and D showing Ack-mCherry (red)
and yki-GFP (green) localization patterns.
(TIF)

induced by hid or rpr. The eye size assay was used to assess the
ability of PR2 overexpression and knockdown to modify both hid
and rpr induced programmed cell death. (A) Hid expression in a
GAL4 background produces a small eye phenotype. Overexpression of PR2 (B) or RNAi mediated knockdown of PR2 (C) in the
GMR-hid, GMR-GAL4 background does not result in modification
of eye size. The dotted oval in panel A has been reproduced in
panels B and C to aid in comparison. (D) Rpr expression in a
GAL4 background also produces a small eye phenotype. Similarly,
overexpression of PR2 (E) or RNAi mediated knockdown of PR2
(F) in the GMR-GAL4, GMR-rpr background does not substantially
modify eye size. The dashed oval in panel D has been reproduced
in panels E and F to aid in comparison.
(TIF)

Figure S5 Ack expression does not induce transcription of yki
targets. Confocal images of third instar eye discs analyzed for
expression of Ack and beta-galactosidase driven by the ex-lacZ
enhancer trap line ex697 in the absence (A–C) or presence (D–F) of
Ack overexpression (posterior is down). The dashed line indicates
the position of the morphogenetic furrow (MF). (A) Betagalactosidase expression pattern in the absence of Ack overexpression shows similar levels of labeling posterior and anterior of
the MF. (B) Ack expression is higher posterior of the MF. (C) An
overlay of panels A and B showing beta-galactosidase (green) and
Ack (red) expression. (D) Beta-galactosidase expression pattern in
the presence of Ack overexpression again shows similar levels of
labeling posterior and anterior of the MF. (E) Overexpression of
Ack can be seen posterior to the MF due to GMR driven
expression. (F) An overlay of panels D and E showing betagalactosidase (green) and Ack (red) expression.
(TIF)

Figure S2 Ack manipulation modifies rpr induced programmed
cell death in the wing disc. The TUNEL assay was used to assess
the effect of Ack transgenes or alleles on rpr induced programmed
cell death. (A–D) TUNEL positive cells are labeled in green and

Figure S6 Suppression of hid induced small eye phenotypes by
RNAi mediated knockdown of Wwox. The eye size assay was used
to assess the ability of Wwox knockdown modify both hid and
hidAla5 induced programmed cell death. (A) Hid expression in a

Supporting Information
Figure S1 PR2 does not modify the small eye phenotypes
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GMR-GAL4 and UAS-Dcr2 expressing background produces a
small eye phenotype. (B) RNAi mediated knockdown of Wwox
suppresses the small eye phenotype. A dotted oval is used to aid in
comparison. (C) Ack expression produces a larger increase in eye
size in a similar genetic background. (D) HidAla5 expression in a
GMR-GAL4 and UAS-Dcr2 expressing background also produces a
small eye phenotype. (E) RNAi mediated knockdown of Wwox
fails to modify the eye size in the GMR-hidAla5, GMR-GAL4; UASDcr2 background. A dashed oval is drawn for comparison. (F) Ack
expression suppresses the small phenotype induced in a GMRhidAla5, GMR-GAL4 background.
(TIF)
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